1. Home
  2. ENSC vs BOXL Comparison

ENSC vs BOXL Comparison

Compare ENSC & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • BOXL
  • Stock Information
  • Founded
  • ENSC 2003
  • BOXL 1985
  • Country
  • ENSC United States
  • BOXL United States
  • Employees
  • ENSC N/A
  • BOXL N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • BOXL Telecommunications Equipment
  • Sector
  • ENSC Health Care
  • BOXL Telecommunications
  • Exchange
  • ENSC Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • ENSC 2.9M
  • BOXL 3.3M
  • IPO Year
  • ENSC N/A
  • BOXL 2017
  • Fundamental
  • Price
  • ENSC $3.29
  • BOXL $1.55
  • Analyst Decision
  • ENSC
  • BOXL Buy
  • Analyst Count
  • ENSC 0
  • BOXL 3
  • Target Price
  • ENSC N/A
  • BOXL $5.00
  • AVG Volume (30 Days)
  • ENSC 4.9M
  • BOXL 25.6K
  • Earning Date
  • ENSC 05-12-2025
  • BOXL 05-07-2025
  • Dividend Yield
  • ENSC N/A
  • BOXL N/A
  • EPS Growth
  • ENSC N/A
  • BOXL N/A
  • EPS
  • ENSC N/A
  • BOXL N/A
  • Revenue
  • ENSC $5,210,031.00
  • BOXL $135,893,000.00
  • Revenue This Year
  • ENSC N/A
  • BOXL $3.88
  • Revenue Next Year
  • ENSC N/A
  • BOXL N/A
  • P/E Ratio
  • ENSC N/A
  • BOXL N/A
  • Revenue Growth
  • ENSC 133.58
  • BOXL N/A
  • 52 Week Low
  • ENSC $1.62
  • BOXL $1.06
  • 52 Week High
  • ENSC $14.67
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 55.92
  • BOXL 50.88
  • Support Level
  • ENSC $3.02
  • BOXL $1.44
  • Resistance Level
  • ENSC $4.85
  • BOXL $1.61
  • Average True Range (ATR)
  • ENSC 0.40
  • BOXL 0.17
  • MACD
  • ENSC 0.27
  • BOXL 0.05
  • Stochastic Oscillator
  • ENSC 51.70
  • BOXL 82.91

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

Share on Social Networks: